Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution?

被引:19
作者
Stephanson, N. N. [1 ]
Signell, P. [1 ]
Helander, A. [1 ,2 ]
Beck, O. [1 ,2 ]
机构
[1] Karolinska Univ Lab, Dept Clin Pharmacol, Stockholm, Sweden
[2] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
来源
JOURNAL OF MASS SPECTROMETRY | 2017年 / 52卷 / 08期
关键词
liquid chromatography-high-resolution mass spectrometry; urine drug testing; screening; new psychoactive substances; RESOLUTION MASS-SPECTROMETRY; SWEDISH STRIDA PROJECT; PSYCHOACTIVE SUBSTANCES; DOPING AGENTS; LEGAL-HIGHS; FUTURE; MS/MS; IDENTIFICATION; METABOLITES; URINALYSIS;
D O I
10.1002/jms.3946
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The influx of new psychoactive substances (NPS) has created a need for improved methods for drug testing in toxicology laboratories. The aim of this work was to design, validate and apply a multi-analyte liquid chromatography-high-resolution mass spectrometry (LC-HRMS) method for screening of 148 target analytes belonging to the NPS class, plant alkaloids and new psychoactive therapeutic drugs. The analytical method used a fivefold dilution of urine with nine deuterated internal standards and injection of 2 mu l. The LC system involved a 2.0 mu m 100 x 2.0 mm YMC-UltraHT Hydrosphere-C18 column and gradient elution with a flow rate of 0.5 ml/min and a total analysis time of 6.0 min. Solvent A consisted of 10 mmol/l ammonium formate and 0.005% formic acid, pH 4.8, and Solvent B was methanol with 10 mmol/l ammonium formate and 0.005% formic acid. The HRMS (Q Exactive, Thermo Scientific) used a heated electrospray interface and was operated in positive mode with 70 000 resolution. The scan range was 100-650 Da, and data for extracted ion chromatograms used +/- 10 ppm tolerance. Product ion monitoring was applied for confirmation analysis and for some selected analytes also for screening. Method validation demonstrated limited influence from urine matrix, linear response within the measuring range (typically 0.1-1.0 mu g/ml) and acceptable imprecision in quantification (CV < 15%). A few analytes were found to be unstable in urine upon storage. The method was successfully applied for routine drug testing of 17 936 unknown samples, of which 2715 (15%) contained 52 of the 148 analytes. It is concluded that the method design based on simple dilution of urine and using LC-HRMS in extracted ion chromatogram mode may offer an analytical system for urine drug testing that fulfils the requirement of a 'black box' solution and can replace immunochemical screening applied on autoanalyzers. Copyright (C) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:497 / 506
页数:10
相关论文
共 27 条
[1]   Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-Experience from the Swedish population [J].
Al-Saffar, Yasir ;
Stephanson, Niclas Nikolai ;
Beck, Olof .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2013, 930 :112-120
[2]   Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project [J].
Bäckberg M. ;
Tworek L. ;
Beck O. ;
Helander A. .
Journal of Medical Toxicology, 2017, 13 (1) :52-60
[3]   Toxicity evaluation of -pyrrolidinovalerophenone (-PVP): results from intoxication cases within the STRIDA project [J].
Beck, Olof ;
Franzen, Lisa ;
Backberg, Matilda ;
Signell, Patrick ;
Helander, Anders .
CLINICAL TOXICOLOGY, 2016, 54 (07) :568-575
[4]   Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS [J].
Beck, Olof ;
Ericsson, Magnus .
BIOANALYSIS, 2014, 6 (17) :2229-2244
[5]   Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse [J].
Beck, Olof ;
Rausberg, Linnea ;
Al-Saffar, Yasir ;
Villen, Tomas ;
Karlsson, Lennart ;
Hansson, Therese ;
Helander, Anders .
DRUG TESTING AND ANALYSIS, 2014, 6 (05) :492-499
[6]   Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs [J].
Bell, Charlotte ;
George, Claire ;
Kicman, Andrew T. ;
Traynor, Allan .
DRUG TESTING AND ANALYSIS, 2011, 3 (7-8) :496-504
[7]   Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays [J].
Bergstrand, Madeleine Pettersson ;
Helander, Anders ;
Hansson, Therese ;
Beck, Olof .
DRUG TESTING AND ANALYSIS, 2017, 9 (04) :640-645
[8]  
Crews BO, 2014, BIOANALYSIS, V6, P2839, DOI [10.4155/BIO.14.163, 10.4155/bio.14.163]
[9]   Evolution of Orbitrap Mass Spectrometry Instrumentation [J].
Eliuk, Shannon ;
Makarov, Alexander .
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 8, 2015, 8 :61-80
[10]  
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2016, EU DRUG MARK REP IN